Discussing Dose Reductions and Interruptions with Patients on Therapy for Endometrial CancerJanuary 6th 2023
Kimberly A. Spickes, CNP, discusses how often patients with endometrial cancer have dose reductions or interruptions at her institution, and who is involved in the decision to dose-reduce.
Educating Patients With Endometrial Cancer on Treatment-Related Adverse EventsDecember 13th 2022
The panel explains how to educate patients on the adverse effects they may experience with chemotherapy, their options for management, and the importance of encouraging patients to contact their care team.
Fertility and Other Treatment Considerations for Patients With Advanced Endometrial CancerNovember 22nd 2022
The panel shares how they determine a treatment regimen for patients with advanced endometrial cancer taking into consideration fertility and family planning, hereditary conditions, and comorbidities.